Skip to main content
Clinical Trials/SLCTR/2014/016
SLCTR/2014/016Not yet recruiting未知

Effect of pentoxyfylline on histological activity and fibrosis of patients with nonalcoholic steatohepatitis

Bangabandhu Sheikh Mujib Medical University0 sites30 target enrollmentStarted: TBDLast updated:
Conditions

Trial Snapshot

Phase
未知
Status
Not yet recruiting
Enrollment
30

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Inclusion Criteria

  • 1. Ultrasonographic evidence of fatty liver
  • 2. Nonalcoholic fatty liver disease activity score greater than or equal to 5 on liver histopathology

Exclusion Criteria

  • 1. Significant alcohol intake(more than 20 gm /day)
  • 2. History of taking drugs that may cause fatty liver(i.e.tamoxifen, valproic acid, amiodarone, methotrexate) or history of taking drugs that have shown benefit in previous Nonalcoholic steatohepatitis studies(i.e.vitamin E ,metformin, thiazolidinedione, fibrates)
  • 3. Chronic viral hepatitis(HBV , HCV)
  • 4. Pregnancy
  • 5. Co-morbid conditions(Chronic Obstructive Pulmonary Disease ,Chronic Kidney Disease, Congestive CF, Myocardial infarction)
  • 6. Liver failure
  • 7. Hypothyroidism
  • 8. Patient who fails to give consent for paired biopsy
  • 9. Wilson's disease and Hemochromatosis

Investigators

Similar Trials